DK1194525T3 - Kombination af mælkesyrebakterier og dens anvendelse til forebyggelse og/eller behandling af infektioner og inflammatoriske tilstande - Google Patents

Kombination af mælkesyrebakterier og dens anvendelse til forebyggelse og/eller behandling af infektioner og inflammatoriske tilstande

Info

Publication number
DK1194525T3
DK1194525T3 DK00940762T DK00940762T DK1194525T3 DK 1194525 T3 DK1194525 T3 DK 1194525T3 DK 00940762 T DK00940762 T DK 00940762T DK 00940762 T DK00940762 T DK 00940762T DK 1194525 T3 DK1194525 T3 DK 1194525T3
Authority
DK
Denmark
Prior art keywords
infections
prevention
treatment
combination
lactic acid
Prior art date
Application number
DK00940762T
Other languages
Danish (da)
English (en)
Inventor
Simone Claudio De
Original Assignee
Actial Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Lda filed Critical Actial Farmaceutica Lda
Application granted granted Critical
Publication of DK1194525T3 publication Critical patent/DK1194525T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/855—Lactobacillus brevis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Birds (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
DK00940762T 1999-06-21 2000-06-16 Kombination af mælkesyrebakterier og dens anvendelse til forebyggelse og/eller behandling af infektioner og inflammatoriske tilstande DK1194525T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000400A IT1306716B1 (it) 1999-06-21 1999-06-21 Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

Publications (1)

Publication Number Publication Date
DK1194525T3 true DK1194525T3 (da) 2006-09-18

Family

ID=11406844

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00940762T DK1194525T3 (da) 1999-06-21 2000-06-16 Kombination af mælkesyrebakterier og dens anvendelse til forebyggelse og/eller behandling af infektioner og inflammatoriske tilstande

Country Status (35)

Country Link
US (1) US7052688B2 (de)
EP (1) EP1194525B1 (de)
JP (3) JP4949580B2 (de)
KR (1) KR100712286B1 (de)
CN (1) CN1227354C (de)
AR (2) AR024579A1 (de)
AT (1) ATE325614T1 (de)
AU (1) AU775452B2 (de)
BR (2) BRPI0011799B1 (de)
CA (1) CA2373375C (de)
CZ (1) CZ298682B6 (de)
DE (1) DE60027894T2 (de)
DK (1) DK1194525T3 (de)
DZ (1) DZ3167A1 (de)
EA (1) EA006037B1 (de)
EE (1) EE04620B1 (de)
ES (1) ES2262522T3 (de)
HK (1) HK1047132B (de)
HU (1) HUP0202051A3 (de)
IL (2) IL146889A0 (de)
IN (1) IN2001KO01233A (de)
IS (1) IS6177A (de)
IT (1) IT1306716B1 (de)
MA (1) MA25775A1 (de)
MX (1) MX236443B (de)
NO (1) NO329324B1 (de)
NZ (1) NZ516022A (de)
PL (1) PL352805A1 (de)
PT (1) PT1194525E (de)
SI (1) SI1194525T1 (de)
SK (1) SK17172001A3 (de)
TR (1) TR200103606T2 (de)
UA (1) UA76696C2 (de)
WO (1) WO2000078322A2 (de)
ZA (1) ZA200200461B (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
HU227086B1 (en) 1999-11-25 2010-06-28 Vakcina Kft Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
JP4603116B2 (ja) * 1999-12-02 2010-12-22 わかもと製薬株式会社 乳酸菌含有組成物、医薬及び食品
SE518097C2 (sv) * 2000-10-03 2002-08-27 Ellen Ab Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
KR100484480B1 (ko) * 2001-05-04 2005-04-20 정 호 김 표면 막처리된 락토바실러스 퍼멘텀 yl-3 캡슐
EP1287745A1 (de) 2001-08-24 2003-03-05 The Procter & Gamble Company Kaubare Zusammmensetzung mit Probiotika
MXPA04001999A (es) * 2001-09-05 2004-07-16 Vsl Pharmaceuticals Inc Bacterias de acido lactico que comprende dinucleotidos de citosina-guanina no metilados para usarse en terapia.
JP4528472B2 (ja) * 2001-11-29 2010-08-18 ビオフェルミン製薬株式会社 歯周病の予防または治療剤
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
KR100458008B1 (ko) * 2002-12-02 2004-11-18 대한민국 가축 생산성 향상 유산균
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
EP1481681A1 (de) * 2003-05-30 2004-12-01 Claudio De Simone Milchsäurebakterienkombination und deren Zusammensetzungen
WO2005000034A2 (en) * 2003-06-23 2005-01-06 Agtech Products, Inc. Lactic bacteria and its use in direct-fed microbials
PL1659885T3 (pl) * 2003-08-11 2013-06-28 Oragenics Inc Kompozycje do utrzymania zdrowia jamy ustnej
ES2237732T3 (es) * 2003-11-03 2005-08-01 Peter-Hansen Volkmann Composicion para el cuidado vaginal.
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
DK1827284T3 (da) * 2004-12-23 2013-10-28 Actial Farmaceutica Lda Indretning og fremgangsmåde til identificering af vaginale sygdomme
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
WO2007031300A1 (en) * 2005-09-13 2007-03-22 Basf Se Microorganisms inhibiting the formation of axillary malodor
US20090130073A1 (en) * 2005-09-19 2009-05-21 Basf Se Microorganisms Inhibiting the Formation of Foot Malodor
DK1951273T3 (da) 2005-10-06 2014-05-05 Probi Ab Anvendelse af lactobacillus til behandling af autoimmune sygdomme
US7563758B2 (en) * 2005-10-06 2009-07-21 E. I. Du Pont De Nemours And Company Enzymatic production of peracids using Lactobacilli having perhydrolysis activity
CN100556414C (zh) * 2005-10-14 2009-11-04 德阳创新生物工程有限公司 一种具免疫调节功能的多菌组合物及其制备方法与用途
CA2671507A1 (en) * 2006-12-19 2008-06-26 Basf Se Uses and methods for preventing and/or treating caries caused by mutans streptococci
US20110020283A1 (en) * 2007-02-22 2011-01-27 Schrezenmeir Juergen Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans
WO2009021585A1 (en) * 2007-08-13 2009-02-19 Dsm Ip Assets B.V. Probiotic bacteria for rducing the occurence of symptoms of winter infections
KR100898491B1 (ko) * 2007-10-10 2009-05-19 주식회사한국야쿠르트 사람의 구강 충치균에 저해능이 있는 스트렙토코커스써머필러스 에이취와이9012 및 이를 이용한 식품
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2133414A1 (de) * 2008-06-11 2009-12-16 Basf Se Anwendungen und Verfahren zur Vorbeugung und/oder Behandlung von Mundgeruch
MX2010013847A (es) 2008-06-13 2011-03-15 Oragenics Inc Uso de bacteria productora de peroxido de hidrogeno para blanquear dientes.
KR101100043B1 (ko) 2009-06-29 2011-12-29 주식회사한국야쿠르트 항염증 효능을 갖는 락토바실러스 플란타룸 에이취와이7711 및 이를 유효성분으로 함유하는 제품
US8506952B2 (en) * 2009-07-03 2013-08-13 James Madison Innovations, Inc. Probiotic compositions and process thereof
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
DE202009011379U1 (de) * 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
JP4942831B2 (ja) * 2010-03-19 2012-05-30 株式会社キティー 抗アレルギー用組成物
KR101062779B1 (ko) 2010-04-28 2011-09-06 삼육대학교산학협력단 충치 유발 세균의 성장 억제 활성을 나타내는 비피도박테리움 아돌레센티스 ｓｐｍ1005 균주 및 상기 비피도박테리움 아돌레센티스 ｓｐｍ1005 균주 또는 이의 배양물을 유효 성분으로 하는 충치 예방용 식품 및 약제학 조성물
KR101068079B1 (ko) * 2010-07-12 2011-09-28 삼육대학교산학협력단 단순포진바이러스에 대한 항바이러스 활성을 갖는 비피도박테리움 아돌레센티스 ｓｐｍ 0214 및 상기 비피도박테리움 아돌레센티스 ｓｐｍ 0214 균주 또는 이의 배양물을 유효 성분으로 함유하는 단순 포진 바이러스 감염의 예방 또는 치료용 조성물
EP2420580A1 (de) * 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotische Zusammensetzung für die orale Gesundheit
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
EP2740482B1 (de) * 2011-08-05 2016-04-20 Kabushiki Kaisha Yakult Honsha Prophylaktikum oder therapeutikum für erkrankungen der mundhöhle
FR2981273B1 (fr) * 2011-10-14 2013-12-20 Gilles Andre Yves Bhat Nouvelle composition pour les muqueuses: tocopherol, macerat huileux de fleurs de calendula dans de l'huile de rose musquee, palmitate de retinol, ubiquinone, ascorbyl palmitate et lactobacillus
RU2577994C1 (ru) * 2011-11-30 2016-03-20 Компани Жервэ Данон Реутерин-вырабатывающие lactobacillus brevis
RU2494724C2 (ru) * 2012-01-13 2013-10-10 Владимир Николаевич Иванов Зубная паста, содержащая лиофилизированную массу живых бифидобактерий
US20150079039A1 (en) 2012-04-13 2015-03-19 The Regents Of The University Of California Sinusitis diagnostics and treatments
KR101506995B1 (ko) * 2012-05-25 2015-03-30 (주)비타바이오 오리나무 수피 추출물 및 유산균을 포함하는 항우식성 조성물
CN102690768B (zh) * 2012-05-31 2014-07-30 江南大学 一株短乳杆菌及其应用
FR2992973B1 (fr) * 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
CN102727531A (zh) * 2012-07-23 2012-10-17 郑州金森生物科技工程有限公司 一种对阴道炎具有治疗和预防作用的活性乳酸菌胶囊
RU2504580C1 (ru) * 2012-08-01 2014-01-20 Вячеслав Михайлович Абрамов ПРОБИОТИЧЕСКИЕ ШТАММЫ Lactobacillus И ИХ КОНСОРЦИУМ ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ УРОГЕНИТАЛЬНЫХ ИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ У ЖЕНЩИН
US20150284675A1 (en) * 2012-10-25 2015-10-08 Compagnie Gervais Danone Streptococcus thermophilus strains for treating helicobacter pylori infection
CN103409334B (zh) * 2013-01-16 2018-07-20 生合生物科技股份有限公司 抑制阴道炎病原菌之乳酸杆菌及其用途
EP2956130A4 (de) 2013-02-14 2016-08-31 Univ Florida Probiotische arginolytische orale zusammensetzungen und verfahren zur herstellung und verwendung der probiotischen arginolytischen oralen zusammensetzungen
US10206959B2 (en) 2013-02-14 2019-02-19 University Of Florida Research Foundation, Inc. Probiotic arginolytic oral compositions and methods of making and using probiotic arginolytic oral compositions
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
EP3013150A4 (de) 2013-06-27 2017-03-08 Starbucks Corporation D/b/a Starbucks Coffee Company Verfahren zur biokonservierung von getränken und anderen nahrungsmitteln
CN117717569A (zh) * 2013-07-05 2024-03-19 恒星生物群落有限公司 口服组合物
CN103798392B (zh) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
CN104232537B (zh) * 2014-09-03 2017-04-12 中国科学院微生物研究所 一株弯曲乳杆菌及其应用
CN104293718B (zh) * 2014-10-11 2017-01-18 中国科学院微生物研究所 一株詹氏乳杆菌及其应用
CN104694414B (zh) * 2014-11-21 2019-05-24 北京百益恒源科技有限公司 一株詹氏乳酸杆菌(Lactobacillus jensenii)及其制药用途
CN104622914A (zh) * 2015-01-06 2015-05-20 占美华 阴道益生菌栓
KR101980252B1 (ko) 2015-05-26 2019-05-21 (주)투라인스 질증 치료용 조성물
RU2619281C2 (ru) * 2015-07-24 2017-05-15 Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт технологии консервирования Способ выработки ферментированного растительного сырья
BR112018003123B1 (pt) * 2015-08-25 2021-09-28 ImmuneBiotech Medical Sweden AB Composição, enema, e, uso de uma composição, de um enema ou de uma ou mais de uma cepa bacteriana isolada
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
CN105362296A (zh) * 2015-11-27 2016-03-02 成都吉氧屋科技有限公司 乳酸菌洗鼻液
EP3196318A1 (de) 2016-01-19 2017-07-26 Symrise AG Probiotika zum ändern der zusammensetzung von oralen biofilmen
GB201600975D0 (en) 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof
AU2017209868B2 (en) * 2016-01-19 2023-08-03 Probi Ab Probiotics for use as anti-inflammatory agents in the oral cavity
KR101720145B1 (ko) * 2016-07-08 2017-04-07 (주)정가진면역연구소 여성 질염 예방 및 개선 기능성 조성물
EP3351259A1 (de) 2017-01-18 2018-07-25 Symrise AG Probiotika zur aggregation mit krankheitsassoziierten spezies in der mundhöhle
DK3517119T3 (da) * 2018-01-26 2021-11-15 Probisearch S L U Sammensætning omfattende ny lactobacillus salivarius-stamme og fremgangsmåde til forebyggelse og behandling af otitis og infektioner i de øvre luftveje
RU2675110C1 (ru) * 2018-04-09 2018-12-17 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция для терапии воспалительных заболеваний слизистых оболочек кишечника на основе штамма Lactobacillus brevis 47f, проявляющая местную противовоспалительную активность
CN112384611B (zh) * 2018-05-23 2024-01-09 Ko生物技术有限公司 卷曲乳杆菌kbl693菌株及其用途
AU2019274351B2 (en) * 2018-05-23 2022-04-07 Kobiolabs, Inc. Lactobacillus gasseri KBL697 strain and use thereof
CN112236155B (zh) * 2018-05-31 2024-10-18 深圳华大生命科学研究院 一种组合物及其应用
KR102164906B1 (ko) * 2018-09-12 2020-10-14 (주)성운파마코피아 락토바실러스 살리바리우스 swpm101 및 락토바실러스 가세리 swpm102를 포함하는 골질환의 예방, 개선 또는 치료용 조성물
KR102063554B1 (ko) 2018-09-12 2020-01-09 (주)성운파마코피아 항진균 활성 또는 항균 활성을 갖는 락토바실러스 가세리 swpm102
JP2022504792A (ja) * 2018-10-10 2022-01-13 セルバトゥス リミテッド 炎症性疾患及び関連する感染の治療方法
CN111088178B (zh) * 2018-10-23 2022-11-22 上海上药信谊药厂有限公司 一种产乳酸和h2o2的乳杆菌及其应用
WO2020210553A1 (en) 2019-04-09 2020-10-15 Dermbiont, Inc. Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
KR102364448B1 (ko) * 2019-12-31 2022-02-17 심민보 프로바이오틱스 및 항생제를 포함하는 항염증용 약학적 조성물 및 이를 이용한 방법
KR102162470B1 (ko) 2020-03-19 2020-10-06 주식회사 비피도 비피도박테리움 슈도카테눌라튬 c-rapo (kctc13986bp), 비피도박테리움 비피덤 att (kctc13474bp) 균주를 포함하는 쇼그렌증후군 억제용 식품 조성물 및 약학 조성물
CN111548970B (zh) * 2020-05-29 2021-03-26 江南大学 一株能够预防和/或治疗幽门螺杆菌感染的卷曲乳杆菌
CN111617025B (zh) * 2020-06-12 2021-01-29 广州市千邦化妆品有限公司 美白祛斑抗糖化的发酵产物化妆品
CN113082149A (zh) * 2021-04-28 2021-07-09 宋颖鹰 植物草本益生菌口腔含片及其制备方法
KR102646766B1 (ko) * 2023-06-14 2024-03-13 일동바이오사이언스(주) 잇몸 질환을 예방하고 구취 생성 억제능을 가지는 비피도박테리움 브레베 idcc 4401 균주를 포함하는 조성물 및 건강기능식품
CN117535209B (zh) * 2024-01-04 2024-03-29 四川厌氧生物科技有限责任公司 左旋短乳杆菌及其在女性生殖道健康中的应用
CN118542885A (zh) * 2024-04-08 2024-08-27 杭州核力欣健实业股份有限公司 一种乳酸菌二联活菌制剂、其制备方法及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6191126A (ja) * 1984-10-09 1986-05-09 Advance Res & Dev Co Ltd 抗歯周症剤
JPS60190707A (ja) * 1984-03-09 1985-09-28 Advance Res & Dev Co Ltd 抗う蝕剤
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5286478A (en) * 1987-11-04 1994-02-15 Rhone-Poulenc Chimie Dentifrice-compatible silica particulates
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
IT1254210B (it) * 1992-02-10 1995-09-14 Simone Claudio De Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
RU2031586C1 (ru) * 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
JPH08507497A (ja) * 1993-03-10 1996-08-13 コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼイション 農業用生体制御剤
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
ES2142919T3 (es) * 1994-05-27 2000-05-01 Agrano Ag Procedimiento de preparacion de medios de cultivo utilizables para el cultivo individual de levaduras y de bacterias lacticas o el cocultivo de levaduras y de bacterias lacticas.
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
JPH08298982A (ja) * 1995-05-02 1996-11-19 Aasu Giken:Kk 複合微生物製剤
CA2245810A1 (en) * 1996-02-14 1997-08-21 The Procter & Gamble Company Urogenital and intestinal compositions
JP4021951B2 (ja) * 1996-03-01 2007-12-12 わかもと製薬株式会社 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
ATE169456T1 (de) * 1996-12-23 1998-08-15 Sitia Yomo Spa Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
JP3028214B2 (ja) * 1997-06-03 2000-04-04 カルピス株式会社 鳥類用生菌剤の投与方法
KR100266752B1 (ko) * 1997-08-07 2001-03-02 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
EP0956858B1 (de) * 1998-04-30 2001-10-31 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

Also Published As

Publication number Publication date
HUP0202051A2 (hu) 2003-01-28
JP6043325B2 (ja) 2016-12-14
CA2373375A1 (en) 2001-11-27
UA76696C2 (uk) 2006-09-15
JP2003502375A (ja) 2003-01-21
BRPI0011799B1 (pt) 2016-12-20
CA2373375C (en) 2014-01-14
EE200100682A (et) 2003-04-15
HUP0202051A3 (en) 2004-07-28
ZA200200461B (en) 2002-09-25
IL146889A (en) 2009-11-18
EA006037B1 (ru) 2005-08-25
WO2000078322A2 (en) 2000-12-28
IS6177A (is) 2001-11-27
CZ20014220A3 (cs) 2002-04-17
TR200103606T2 (tr) 2002-04-22
IL146889A0 (en) 2002-08-14
EP1194525A2 (de) 2002-04-10
JP2012110334A (ja) 2012-06-14
EA200200059A1 (ru) 2003-02-27
WO2000078322A3 (en) 2001-06-28
EP1194525B1 (de) 2006-05-10
AU5566000A (en) 2001-01-09
NZ516022A (en) 2003-10-31
BR0011799A (pt) 2002-03-12
AR024579A1 (es) 2002-10-16
DE60027894D1 (de) 2006-06-14
KR100712286B1 (ko) 2007-04-27
SK17172001A3 (sk) 2002-05-09
DE60027894T2 (de) 2006-11-16
IT1306716B1 (it) 2001-10-02
CN1357038A (zh) 2002-07-03
MXPA01013239A (es) 2004-06-03
BRPI0017622B1 (pt) 2016-12-06
NO20016291D0 (no) 2001-12-20
PL352805A1 (en) 2003-09-08
US20020094328A1 (en) 2002-07-18
US7052688B2 (en) 2006-05-30
AU775452B2 (en) 2004-08-05
ES2262522T3 (es) 2006-12-01
NO329324B1 (no) 2010-09-27
CZ298682B6 (cs) 2007-12-19
JP4949580B2 (ja) 2012-06-13
MA25775A1 (fr) 2003-07-01
JP5969764B2 (ja) 2016-08-17
IN2001KO01233A (de) 2006-03-17
PT1194525E (pt) 2006-09-29
NO20016291L (no) 2002-02-20
MX236443B (es) 2006-05-03
KR20020033643A (ko) 2002-05-07
HK1047132B (zh) 2006-04-13
ITRM990400A1 (it) 2000-12-21
SI1194525T1 (sl) 2006-10-31
JP2015043775A (ja) 2015-03-12
ATE325614T1 (de) 2006-06-15
CN1227354C (zh) 2005-11-16
EE04620B1 (et) 2006-04-17
AR086677A2 (es) 2014-01-15
HK1047132A1 (en) 2003-02-07
DZ3167A1 (fr) 2000-12-28
ITRM990400A0 (it) 1999-06-21

Similar Documents

Publication Publication Date Title
DK1194525T3 (da) Kombination af mælkesyrebakterier og dens anvendelse til forebyggelse og/eller behandling af infektioner og inflammatoriske tilstande
DK1773361T4 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
PT1322318E (pt) Utilização de bactérias ácido lácticas probióticas para prevenção de reacções inflamatórias ou alérgicas ou imunossupressão induzidas por radiações ultravioleta na pele
NO20034430L (no) Tiohydantoiner og anvendelse derav for behandling av diatbetes
NO20016149D0 (no) Indol-derivater og deres anvendelse for behandling av osteporose blant andre applikasjoner
DK1183269T3 (da) Svækkede mikroorganismer til behandlingen af infektion
DK1227827T3 (da) Mælkesyrebakterie til behandling og/eller forebyggelse af giardiasis
NO20025134L (no) Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr
DK1341786T3 (da) Substituerede derivater af aminofuran-2-yl-eddikesyre og aminothien-2-yl-eddikesyre og anvendelsen deraf til behandling af migræner og smerte
DK1175221T3 (da) Mælkesyrebakterier med anxiolytiske egenskaber og anvendelser deraf
NO20024488L (no) Anvendelse av melkesyrebakterier for behandling av bukhinnebetennelse
DE60125212D1 (de) Verwendung von Aivlosin zur Behandlung und Prevention der Lawsonia-Infektionen in Schweinen.
NO20013939L (no) Behandling av kroniske virusinfeksjoner med M. vaccae
DK1140090T3 (da) Anvendelse af phanquinon til behandlingen eller hindringen af hukommelsessvigt
GB0107840D0 (en) Biological materials and methods for use in the prevention or treatment of infections:I
GB0107837D0 (en) Biological materials and methods for use in the prevention or treatment of infections:II
GB0013115D0 (en) Biological materials and methods for use in the prevention or treatment of infections
IT1306143B1 (it) Composizione per la prevenzione ed il trattamento delle alterazionimentali e comportamentali.